Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
1. 系统已在2025-11-26 13:04:49对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1016/S0140-6736(21)00933-8
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673621009338
其他信息:
出版社: Elsevier BV
作者: Jesus G Berdeja; Deepu Madduri; Saad Z Usmani; Andrzej Jakubowiak; Mounzer Agha; Adam D Cohen; A Keith Stewart; Parameswaran Hari; Myo Htut; Alexander Lesokhin; Abhinav Deol; Nikhil C Munshi; Elizabeth O'Donnell; David Avigan; Indrajeet Singh; Enrique Zudaire; Tzu-Min Yeh; Alicia J Allred; Yunsi Olyslager; Arnob Banerjee; Carolyn C Jackson; Jenna D Goldberg; Jordan M Schecter; William Deraedt; Sen Hong Zhuang; Jeffrey Infante; Dong Geng; Xiaoling Wu; Marlene J Carrasco-Alfonso; Muhammad Akram; Farah Hossain; Syed Rizvi; Frank Fan; Yi Lin; Thomas Martin; Sundar Jagannath
